GLP-1 receptor agonists: reminder of potential side effects and awareness of misuse
When dose escalation outpaces the bodys ability to adapt, side effects may interfere with nutrition, hydration, and daily function
Allergy-wise, the risk is very low
Weight regain after stopping GLP-1 medications is common, though data specific to retatrutide discontinuation is limited
By focusing on personalized, medically supervised weight loss solutions, we empower individuals to take control of their health and achieve their weight loss goals safely and effectively
Figure 3 These findings indicated that MAPKAPK2 could reduce ROS production and enhance antioxidant capacity, providing phenotypic evidence that precedes further functional validation of its enzymatic activity under oxidative stress